Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions The latest update is out from Genprex ( (GNPX) ). On January 6, 2026, Genprex reported positive preliminary ...

Preliminary Preclinical Data Demonstrates In Vivo Proof-of-Concept for Novel Diabetes Gene Therapy in Type 2 Diabetic Non-Human Primates GPX-002 Rejuvenated Exhausted ...

Based on the consensus FY2027 adj EPS estimates of $2.99, there is an expanded upside potential of +69.2% to my long-term ...

M+ cash runway to 2029, bitopertin FDA NDA/accelerated approval catalyst, and DISC-0974 myelofibrosis data—read now.

After 332 hours of testing grounding sheets, Napa's consumer reports identifies the best grounding sheets available on the ...

Memory may not derail the AI boom, but it is increasingly likely to shape how fast it grows, who benefits first, and at what ...

This normalization of mobile finance has important implications. Users are not experimenting with FinTech platforms on the ...

Collagen is the most abundant protein in the human body and has an important role in healthy tissue as well as in a range of prevalent diseases. Medical research and diagnostics hence call for means ...

Much like the space race of 60-70 years ago, the winners of this arms race will establish all new power and influence on the ...

Kazuo Ueda, the Bank of Japan Governor, plans to keep hiking interest rates. The BOJ's next move depends on the economic ...